Electrophysiology Market to Reach $22.65 Bn, Globally, by 2030 at 14.4% CAGR | BOSTON SCIENTIFIC CORPORATION, Medtronic

March 12, 2025 04:47 AM PDT | By EIN Presswire
 Electrophysiology Market to Reach $22.65 Bn, Globally, by 2030 at 14.4% CAGR | BOSTON SCIENTIFIC CORPORATION, Medtronic
Image source: EIN Presswire
PORTLAND, KS, UNITED STATES, March 12, 2025 /EINPresswire.com/ -- Alarming rise in prevalence of cardiac arrhythmia, advancements in technology in pharmaceutical and medical device industry for manufacturing of electrophysiology products, rise in demand for cardiac ablation procedure, and increase in number of approval for electrophysiology catheter and other devices are expected to notably contribute toward the growth of the global electrophysiology market during the forecast period.

According to the report published by Allied Market Research, the global electrophysiology market was estimated at $6.49 billion in 2020 and is expected to hit $22.65 billion by 2030, registering a CAGR of 14.4% from 2021 to 2030.

Download Report Summary- https://www.alliedmarketresearch.com/request-sample/452

Drivers, restraints, and opportunities-

Rise in prevalence of cardiac arrhythmia, increase in demand for minimally invasive procedures, advancements in technology in the field of electrophysiology, and surge in number of approvals for electrophysiology devices drive the growth of the global electrophysiology market. On the other hand, high cost of electrophysiological devices impedes the growth to some extent. However, increase in number of key players to manufacture advanced electrophysiology devices is expected to create lucrative opportunities in the industry.

The EP ablation catheters segment to retain the lion's share-

On the basis of product, the EP ablation catheters segment held the major share in 2020, garnering more than two-thirds of the global electrophysiology market. The same segment is also expected to grow at the fastest CAGR of 15.20% throughout the forecast period. This is due to surge in number of ablation procedure and advancements in technology to manufacture innovative electrophysiology ablation catheters.

The hospitals & cardiac centers segment to dominate by 2030-

On the basis of end user, the hospitals & cardiac centers segment contributed to the lion's share in 2020, holding nearly three-fourths of the global electrophysiology market. The same segment is also anticipated to cite the fastest CAGR of 14.90% from 2021 to 2030. This is owing to increase in development of hospital infrastructure, and rise in initiatives taken by government & private organizations to develop hospitals facilities.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/452

North America held the major share in 2020-

By region, the market across North America dominated in 2020, garnering more than two-thirds of the global electrophysiology market. This is due to rise in prevalence of cardiac arrhythmia and increase in number of approvals for electrophysiology devices in the province. Simultaneously, the Asia-Pacific region is expected to cite the fastest CAGR of 15.10% throughout the forecast period. This is attributed to rise in prevalence of atrial fibrillation, advancements in technology in the field of electrophysiology, growth in health care expenditures, and increase in geriatric population in the region.

Key players in the industry-

Biotronik SE & Co. KG
Boston Scientific Corporation
Abbott Laboratories
CardioFocus, Inc.
GE Healthcare
Koninklijke Philips N.V.
Medtronic Plc.
MicroPort Scientific Corporation
Siemens Healthineers AG.
Johnson & Johnson, Inc.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
5038946022 ext.
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next